Current partner codePEPTIDESDE
PeptideStat
Menu

Vendors

Compare pricesVendor directoryVendor reviewsDiscount codesLab tests & COAs

Research

ResearchDatabaseClinical trials

Tools

All calculatorsReconstitutionAccumulationUnit converterPeptide chemistry

Therapeutic-area index

OtherPeptide Trials.

Explore peptide clinical trials tagged to the other condition group in the current local registry snapshot. Condition groups are PeptideStat search classifications layered over source-reported indications.

Studies
1,940
Recruiting
290
Completed
998
Results posted
441
Countries
94
Avg enrollment
324

Velocity

Other trials by start year

Study start year · indexed snapshot

1491127537019971997: 2 trials1998: 0 trials1999: 2 trials2000: 5 trials2001: 13 trials2002: 14 trials20032003: 21 trials2004: 26 trials2005: 26 trials2006: 52 trials2007: 41 trials2008: 46 trials20092009: 52 trials2010: 45 trials2011: 54 trials2012: 66 trials2013: 54 trials2014: 64 trials20152015: 75 trials2016: 82 trials2017: 97 trials2018: 105 trials2019: 117 trials2020: 91 trials20212021: 117 trials2022: 113 trials2023: 138 trials2024: 146 trials2025: 123 trials2026: 149 trials20272027: 3 trials20282028: 1 trials

Development

Trials by phase

Early Phase 134
Phase 1256
Phase 2532
Phase 3416
Phase 4288

Industry

Leading sponsors

Ipsen42
Novartis36
Novo Nordisk32
Eli Lilly29
Shire28
GlaxoSmithKline26
Stealth BioTherapeutics Inc.26
Amicus Therapeutics21

Therapeutic areas

Condition groups

Compound leaders

Most represented peptides.

01Desmopressin7502Lanreotide7503Goserelin7404Leuprolide7405Triptorelin7406Bivalirudin7307Cetrorelix7308Pasireotide7309Carbetocin7210Ganirelix7211Terlipressin7212Degarelix70

Study explorer

Search this collection.

1,940 matching studies